The present disclosure is directed to indicating systems and methods for incontinence products. The indicating system may include an indicator panel for an incontinence product that is adapted to provide a qualitative or quantitative indication of a characteristic of a liquid absorbed by the indicator panel.

Measurement devices include a housing featuring a channel, where the housing is dimensioned to be worn in an oral cavity of a user and the channel is positioned such that at least some of the user's teeth are positioned in the channel when the housing is worn, a first sensor positioned within or on a surface of the housing, where the first sensor is configured to generate a first measurement signal that includes information about a position of the measurement device, and a second sensor positioned within or on a surface of the housing, where the second sensor is configured to generate a second measurement signal that includes information about at least one of a biochemical and an electrical property of the user's oral cavity.

Transient molecules in the gastrointestinal (GI) tract, such as nitric oxide and hydrogen sulfide, are important signals and mediators of inflammatory bowel disease (IBD). Because these molecules may be short-lived in the body, they are difficult to detect. To track these reactive molecules in the GI tract, a miniaturized device has been developed that integrates genetically engineered probiotic biosensors with a custom-designed photodetector and readout chip. Leveraging the molecular specificity of living sensors, bacteria were genetically encoded to respond to IBD-associated molecules by luminescing. Low-power electronic readout circuits (e.g., using nanowatt power) integrated into the device convert the light from just 1 μL of bacterial culture into a wireless signal. Biosensor monitoring was demonstrated in the GI tract of small and large animal models and integration of all components into a sub-1.4 cm.sup.3 ingestible form factor capable of supporting wireless communication. The wireless detection of short-lived, disease-associated molecules may support earlier diagnosis of disease than is currently possible, more accurate tracking of disease progression, and more timely communication between patient and their care team supporting remote personalized care.

Peritoneal dialysis, such as automated peritoneal dialysis (“APD”) is provided with any one or more or all of the following sensing or feedback features: impedance sensing to detect peritonitis, temperature sensing to detect peritonitis, bio-MEMS sensing to detect peritonitis, and glucose control for diabetes patients, wherein each sensing or feedback feature analyzes patient effluent fluid or fluid dwelling within a patient's peritoneal cavity.

A sanitary device for the urine glucose test includes a urine container formed on an inner wall of a main body, and a measuring module with an inner space mounted at a bottom of the urine container. Within the inner space, a lens attaches to the bottom of the urine container, a rail faces a bottom surface of the lens, and a driving module moves a light unit shooting a detection beam to a measuring surface of the lens along the rail. The measuring surface contacts urine in the urine container, and reflects the detection beam out of the bottom surface into a sensor. The sensor is electrically connected to a processor. The processor determines a urine glucose level and generates a urine glucose level data instantly from an angle of incidence of the detection beam on the measuring surface and from a beam intensity signal from the sensor.

A device for monitoring one or more health conditions of a subject in need thereof has a plurality of sensor arrays adapted to detect, from a skin surface of the subject, a plurality of volatile organic compounds (VOCs), one or more vital signs, or both, and to generate electrical signals; one or more processors for processing the electrical signals from the plurality of sensors, generating data, and diagnosing one or more health conditions of the subject by correlating the generated data with the one or more health conditions; an interface for outputting data and/or receiving input commands; and a fixing member for placing the device to the skin surface of the subject.

This invention provides an effective, targeted therapy for persons suffering from an endotype of chronic rhinosinusitis which is characterized by elevated levels of LTE4 in urine.

A monitoring device configured for insertion into a conduit of a subject includes a housing, at least one physiological sensor coupled to the housing, a transmitter coupled to the housing, an expandable element, inflatable element, stretched membrane or balloon coupled to the housing and configured to occlude at least a portion of the conduit, a power source attached to the housing, and a processor coupled to the housing and operatively coupled to memory containing computer instruction causing the monitoring device to obtain physiological information via the at least one physiological sensor where the physiological information includes one or more of pulse rate information, body temperature information, breathing rate information, blood pressure information, cardiac output information, or blood gas level information, and processing and analyzing the physiological information to provide a result.

Systems and methods for monitoring eyedrop usage are disclosed. Example embodiments include a system to monitor eyedrop usage. The system may include a detection and activation circuit couplable to a wireless biosensor and an eyedrop dispenser. The detection and activation circuit may include a pressure transducer that transmits a signal upon detecting a force at, or above, a threshold value. The system may also include a wireless biosensor insertable into a region of an eyelid. The wireless biosensor may include a sensor to detect the physical change and the chemical change of tears as a result of eyedrop usage. The wireless biosensor may also include a transceiver to receive the signal that activates the sensor for an activation time.

A contact lens according to an embodiment of the present disclosure includes: a lens section that is worn on an eyeball; an acquisition section that is provided in the lens section and acquires biological information; and an output section that outputs the biological information acquired by the acquisition section to an external apparatus to be worn on a human body. The output section has one or a plurality of coil antennas extending along a front surface of the lens section, and a capacitor that is coupled to the one or the plurality of coil antennas in series or in parallel.